FDA Clears Emerging AI-Enabled Teleradiology Platform
The Rology teleradiology platform may improve access to top tier-imaging interpretation for stand-alone imaging centers, rural facilities and low-income patients.
The Food and Drug Administration (FDA) has granted 510(k) clearance for Rology, an on-demand teleradiology platform, which is currently being utilized in nine countries, and may bolster the capabilities of stand-alone imaging centers in the United States.
In addition to facilitating seamless acquisition of DICOM images and encryption of data, Rology said the artificial intelligence (AI)-enabled teleradiology platform matches the imaging review requests with top radiologists based upon subspeciality and availability. The company noted the Rology platform has access to a network of 306 reviewing radiologists.
Rology noted the teleradiology platform features a variety of FDA-cleared modules including an automatic image acquisition tool (Rology Connect), a workflow management system and DICOM viewer. The company added that 69 percent of scans with the Rology platform undergo peer review.
Rology emphasized that the zero-footprint platform improves access to top-tier imaging, noting that 39 percent of its scan requests originate from rural areas and 46 percent of its scans have been performed for low-income patients.
"This clearance doesn't just represent technological advancement, it symbolizes hope for countless medical providers, especially (stand-alone imaging centers) and the underserved public hospitals,” emphasized Moaaz Hossam, the chief business officer of Rology. “With this platform, they can now provide world-class radiology services, ensuring that every patient, irrespective of their location or the institution's size, receives top-notch care.”
Can CT-Based AI Help Predict Renal Function Decline After Radioligand Therapy for mCRPC?
February 25th 2025In patients who had at least four cycles of 177Lu-PSMA-I&T for mCRPC, new research shows that a 10 percent or greater decrease in total kidney volume on CT at six months has a 90 percent AUC for predicting estimated glomerular filtration rates (eGFRs) of 30 percent or greater at one year.
Study Assesses Potential of Seven-Minute AI-Enhanced 3T MRI of the Shoulder
February 20th 2025Researchers found that the use of seven-minute threefold parallel imaging-accelerated deep learning 3T MRI had 89 percent sensitivity for supraspinatus-infraspinatus tendon tears and 93 percent sensitivity for superior labral tears.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.
